z-logo
open-access-imgOpen Access
The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
Author(s) -
Paolo Giani,
Daniela de Totero
Publication year - 2021
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2021.73
Subject(s) - hepatocyte growth factor , multiple myeloma , autocrine signalling , c met , paracrine signalling , cancer research , medicine , bone marrow , disease , chemotherapy , immunology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom